These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12411925)

  • 1. Pharmacological prevention of Parkinson disease in Drosophila.
    Auluck PK; Bonini NM
    Nat Med; 2002 Nov; 8(11):1185-6. PubMed ID: 12411925
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's pathology in a fly.
    Haass C; Kahle PJ
    Nature; 2000 Mar; 404(6776):341, 343. PubMed ID: 10746706
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurobiology. Chaperones take flight.
    Helfand SL
    Science; 2002 Feb; 295(5556):809-10. PubMed ID: 11823628
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole-mount analysis reveals normal numbers of dopaminergic neurons following misexpression of alpha-Synuclein in Drosophila.
    Pesah Y; Burgess H; Middlebrooks B; Ronningen K; Prosser J; Tirunagaru V; Zysk J; Mardon G
    Genesis; 2005 Apr; 41(4):154-9. PubMed ID: 15789427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
    Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN
    J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology. Of flies and mice.
    Dawson VL
    Science; 2000 Apr; 288(5466):631-2. PubMed ID: 10799001
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease.
    Scherzer CR; Jensen RV; Gullans SR; Feany MB
    Hum Mol Genet; 2003 Oct; 12(19):2457-66. PubMed ID: 12915459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of alpha-synuclein in Parkinson's disease: insights from animal models.
    Maries E; Dass B; Collier TJ; Kordower JH; Steece-Collier K
    Nat Rev Neurosci; 2003 Sep; 4(9):727-38. PubMed ID: 12951565
    [No Abstract]   [Full Text] [Related]  

  • 9. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
    McLean PJ; Klucken J; Shin Y; Hyman BT
    Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury.
    Giffard RG; Xu L; Zhao H; Carrico W; Ouyang Y; Qiao Y; Sapolsky R; Steinberg G; Hu B; Yenari MA
    J Exp Biol; 2004 Aug; 207(Pt 18):3213-20. PubMed ID: 15299042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
    Lotharius J; Brundin P
    Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hsp90: how a chaperone becomes a pharmacological target].
    Jacquemin-Sablon A
    Bull Cancer; 2003 Nov; 90(11):935-6. PubMed ID: 14706894
    [No Abstract]   [Full Text] [Related]  

  • 14. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.
    Outeiro TF; Kontopoulos E; Altmann SM; Kufareva I; Strathearn KE; Amore AM; Volk CB; Maxwell MM; Rochet JC; McLean PJ; Young AB; Abagyan R; Feany MB; Hyman BT; Kazantsev AG
    Science; 2007 Jul; 317(5837):516-9. PubMed ID: 17588900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and Parkinson's disease: is the killer in the house?
    Chesselet MF
    Mol Psychiatry; 2003 Apr; 8(4):369-70. PubMed ID: 12740592
    [No Abstract]   [Full Text] [Related]  

  • 16. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Releasing the nerve cell killers.
    Welch K; Yuan J
    Nat Med; 2002 Jun; 8(6):564-5. PubMed ID: 12042803
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
    Liu WG; Lu GQ; Li B; Chen SD
    Parkinsonism Relat Disord; 2007 Mar; 13(2):77-88. PubMed ID: 16963309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
    Maguire-Zeiss KA; Short DW; Federoff HJ
    Brain Res Mol Brain Res; 2005 Mar; 134(1):18-23. PubMed ID: 15790526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.